We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$70.1B
AUM Growth
-$3.23B
Cap. Flow
-$4.59B
Cap. Flow %
-6.55%
Top 10 Hldgs %
10.04%
Holding
5,020
New
596
Increased
1,359
Reduced
1,925
Closed
795

Sector Composition

Rank Sector Weight
1 Communication Services 9.11%
2 Healthcare 7.95%
3 Consumer Discretionary 7.93%
4 Financials 7.4%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHI
2276
DELISTED
INPHI CORPORATION
IPHI
$2.18M ﹤0.01%
135,274
+92,207
+214% +$1.25M
POT
2277
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
$2.17M ﹤0.01%
60,000
-563,100
-90% -$18.9M
CASC
2278
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.17M ﹤0.01%
121,002
+30,949
+34% +$508K
SGMO
2279
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.17M ﹤0.01%
119,849
+87,370
+269% +$1.68M
FTK icon
2280
CALL
Flotek Industries
FTK
$856M
$2.16M ﹤0.01%
12,933
+8,766
+210% +$1.23M
JBHT icon
2281
JB Hunt Transport Services
JBHT
$26.1B
$2.16M ﹤0.01%
30,001
+510
+2% +$37.6K
NVS icon
2282
Novartis
NVS
$304B
$2.16M ﹤0.01%
28,317
-70,041
-71% -$5.1M
ETFC
2283
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$2.16M ﹤0.01%
93,700
+42,300
+82% +$927K
ZLTQ
2284
CALL
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.16M ﹤0.01%
110,000
+33,300
+43% +$650K
WFM
2285
CALL
DELISTED
Whole Foods Market Inc
WFM
$2.15M ﹤0.01%
42,300
-2,700
-6% -$144K
PDCE
2286
PUT
DELISTED
PDC Energy, Inc.
PDCE
$2.14M ﹤0.01%
34,400
-25,600
-43% -$1.4M
CA
2287
PUT
DELISTED
CA, Inc.
CA
$2.14M ﹤0.01%
69,000
GPN icon
2288
CALL
Global Payments
GPN
$23.9B
$2.13M ﹤0.01%
60,000
+20,000
+50% +$687K
GPN icon
2289
PUT
Global Payments
GPN
$23.9B
$2.13M ﹤0.01%
60,000
+20,000
+50% +$687K
VTOL icon
2290
Bristow Group
VTOL
$1.34B
$2.13M ﹤0.01%
36,365
-276
-0.8% -$16.2K
GNCMA
2291
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$2.13M ﹤0.01%
186,865
-43,949
-19% -$465K
PL
2292
PUT
DELISTED
PROTECTIVE LIFE CORP
PL
$2.13M ﹤0.01%
40,500
CZR
2293
DELISTED
Caesars Entertainment Corporation
CZR
$2.13M ﹤0.01%
112,057
-330,820
-75% -$7.63M
PHIIK
2294
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$2.13M ﹤0.01%
48,132
-1,469
-3% -$59.6K
STBZ
2295
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$2.13M ﹤0.01%
120,292
-25,056
-17% -$436K
TYL icon
2296
Tyler Technologies
TYL
$13.7B
$2.13M ﹤0.01%
25,407
+16,807
+195% +$1.62M
AIFU
2297
AIFU Inc
AIFU
$190M
$2.13M ﹤0.01%
709
-54
-7% -$143K
XXIA
2298
DELISTED
Ixia
XXIA
$2.12M ﹤0.01%
+169,552
New +$2.17M
FWONA icon
2299
CALL
Liberty Media Series A
FWONA
$23.3B
$2.12M ﹤0.01%
91,189
-151,982
-63% -$3.63M
NSU
2300
DELISTED
Nevsun Resources Ltd.
NSU
$2.12M ﹤0.01%
628,480
-210,777
-25% -$785K

Similar funds

D.E. Shaw & Co's Q1 2014 Portfolio in Review

As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.1% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in Veren worth $53.3M.

  • D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
  • D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
  • D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
  • D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.

Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.